Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | TECH | KRYS | ||
| Company | Acceleron Pharma | Bio-Techne Corp | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 72.02 | 368.26 | ||
| High | 179.85 | 72.21 | 368.70 | ||
| Low | 177.06 | 71.99 | 360.07 | ||
| Last | 178.75 | 72.03 | 366.85 | ||
| Change | -0.93 | unch | +3.57 | ||
| Percent Change | -0.52% | unch | +0.98% | ||
| Volume | 7,884,200 | 6,052,000 | 301,900 | ||
| 20-Day Average Volume | 1,302,050 | 4,313,555 | 581,935 | ||
| Previous | 179.68 | 72.03 | 363.28 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 71.50 | 355.23 | ||
| 20-Day Raw Stochastic | 84.01% | 82.13% | 73.25% | ||
| 20-Day Relative Strength | 70.12 | 70.94 | 58.81 | ||
| Weighted Alpha | +57.78 | +34.01 | +132.15 | ||
| Today's Opinion | 100% Buy | 88% Buy | 96% Buy | ||
| Yesterday's Opinion | 100% Buy | 88% Buy | 96% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | +0.36% since 07/23/26 | +12.02% since 07/23/26 | ||
| Low | 173.17 on 11/16/21 | 71.58 on 07/27/26 | 326.01 on 07/24/26 | ||
| High | 179.94 on 11/17/21 | 72.36 on 07/29/26 | 369.00 on 07/29/26 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +1.95% since 06/30/26 | -1.30% since 06/30/26 | ||
| Low | 172.25 on 10/20/21 | 70.49 on 07/08/26 | 325.00 on 07/21/26 | ||
| High | 179.94 on 11/17/21 | 72.36 on 07/29/26 | 382.13 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | +30.21% since 04/30/26 | +39.88% since 04/30/26 | ||
| Low | 120.20 on 08/20/21 | 43.19 on 05/15/26 | 251.97 on 05/04/26 | ||
| High | 189.99 on 09/29/21 | 72.36 on 07/29/26 | 382.54 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +12.39% since 01/30/26 | +31.37% since 01/30/26 | ||
| Low | 113.49 on 07/15/21 | 43.19 on 05/15/26 | 242.00 on 03/31/26 | ||
| High | 189.99 on 09/29/21 | 72.36 on 07/29/26 | 382.54 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,277,665 | 10,709,491 | ||
| Shares Outstanding, K | 61,156 | 156,569 | 29,480 | ||
| Annual Sales, $M | 92,520,000 | 1,219,640,000 | 389,130,000 | ||
| Annual Net Income, $M | -166,030,000 | 73,400,000 | 204,830,000 | ||
| Last Qtr Sales, $M | 34,200,000 | 311,420,000 | 116,360,000 | ||
| Last Qtr Income, $M | -70,470,000 | 51,050,000 | 55,930,000 | ||
| 60-Month Beta | 0.13 | 1.29 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 0.53 on 05/06/26 | 1.83 on 05/04/26 | ||
| Latest Earnings Date | 02/24/22 | 08/05/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | 0.080 on 05/18/26 | N/A | ||
| Next Ex-Dividend Date | N/A | 05/18/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.42 | 48.69 | ||